Elucidating molecular mass and shape of a neurotoxic aβ oligomer

ACS Chemical Neuroscience

Volumn 5, Issue 12, 2014, Pages 1238-1245

  Sebollela, Adriano ^a,c   Mustata, Gina Mirela ^b,d   Luo, Kevin ^a   Velasco, Pauline T ^a   Viola, Kirsten L ^a   Cline, Erika N ^a   Shekhawat, Gajendra S ^b   Wilcox, Kyle C ^a   Dravid, Vinayak P ^b   Klein, William L ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF SÃO PAULO   (Brazil)

^d SIMMONS COLLEGE   (United States)

Author keywords

AFM; Alzheimer's disease; A oligomer; Neurotoxicity; NU4 antibody

Indexed keywords

AMYLOID BETA PROTEIN; MONOCLONAL ANTIBODY; OLIGOMER; ANTIBODY; IMMUNOTOXIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY LABELING; ARTICLE; ATOMIC FORCE MICROSCOPY; BINDING AFFINITY; COMPLEX FORMATION; CONTROLLED STUDY; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPAL NEURONAL CULTURE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOLECULAR WEIGHT; NEUROTOXICITY; NONHUMAN; PROTEIN CONFORMATION; PROTEIN INTERACTION; RAT; WESTERN BLOTTING; ANIMAL; BRAIN; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; FEMALE; HIPPOCAMPUS; HUMAN; IMMUNOLOGY; MAMMALIAN EMBRYO; METABOLISM; NERVE CELL; PATHOLOGY; PREGNANCY; SIZE EXCLUSION CHROMATOGRAPHY; SPRAGUE DAWLEY RAT;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIBODIES; BRAIN; CELLS, CULTURED; CHROMATOGRAPHY, GEL; EMBRYO, MAMMALIAN; FEMALE; HIPPOCAMPUS; HUMANS; IMMUNOTOXINS; MICROSCOPY, ATOMIC FORCE; NEURONS; PREGNANCY; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84918535270     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn500156r     Document Type: Article

References (44)

1. Thies, W., Bleiler, L., and Assoc, A. s. (2013) 2013 Alzheimer's disease facts and figures Alzheimer's Association. Alzheimer's Dementia 9, 208-245.
2. Gralle, M., and Ferreira, S. T. (2007) Structure and functions of the human amyloid precursor protein: The whole is more than the sum of its parts. Prog. Neurobiol. 82, 11-32.
3. Klein, W. L., Krafft, G. A., and Finch, C. E. (2001) Targeting small A beta oligomers: The solution to an Alzheimer's disease conundrum? Trends Neurosci. 24, 219-224.
4. Hardy, J., and Selkoe, D. J. (2002) Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
5. Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., Wals, P., Zhang, C., Finch, C. E., Krafft, G. A., and Klein, W. L. (1998) Diffusible, nonfibrillar ligands derived from A beta(1-42) are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. U.S.A. 95, 6448-6453.
6. Krafft, G. A., and Klein, W. L. (2010) ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology 59, 230-242.
7. Benilova, I., Karran, E., and De Strooper, B. (2012) The toxic A beta oligomer and Alzheimer's disease: An emperor in need of clothes. Nat. Neurosci. 15, 349-357.
8. Broersen, K., Rousseau, F., and Schymkowitz, J. (2010) The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: Oligomer size or conformation? Alzheimer's Res. Ther. 2, 12.
9. Benilova, I., and De Strooper, B. (2011) An overlooked neurotoxic species in Alzheimer's disease. Nat. Neurosci. 14, 949-950.
10. Reed, M. N., Hofmeister, J. J., Jungbauer, L., Welzel, A. T., Yu, C. J., Sherman, M. A., Lesne, S., LaDu, M. J., Walsh, D. M., Ashe, K. H., and Cleary, J. P. (2011) Cognitive effects of cell-derived and synthetically derived A beta oligomers. Neurobiol. Aging 32, 1784-1794.
11. Figueiredo, C. P., Clarke, J. R., Ledo, J. H., Ribeiro, F. C., Costa, C. V., Melo, H. M., Mota-Sales, A. P., Saraiva, L. M., Klein, W. L., Sebollela, A., De Felice, F. G., and Ferreira, S. T. (2013) Memantine rescues transient cognitive impairment caused by high-molecular-weight abeta oligomers but not the persistent impairment induced by low-molecular-weight oligomers. J. Neurosci. 33, 9626-9634.
12. Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., and Selkoe, D. J. (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416, 535-539.
13. Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., and Ashe, K. H. (2005) Natural oligomers of the amyloid-protein specifically disrupt cognitive function. Nat. Neurosci. 8, 79-84.
14. Shankar, G. M., Li, S. M., Mehta, T. H., Garcia-Munoz, A., Shepardson, N. E., Smith, I., Brett, F. M., Farrell, M. A., Rowan, M. J., Lemere, C. A., Regan, C. M., Walsh, D. M., Sabatini, B. L., and Selkoe, D. J. (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat. Med. 14, 837-842.
15. Cizas, P., Budvytyte, R., Morkuniene, R., Moldovan, R., Broccio, M., Losche, M., Niaura, G., Valincius, G., and Borutaite, V. (2010) Size-dependent neurotoxicity of beta-amyloid oligomers. Arch. Biochem. Biophys. 496, 84-92.
16. Brouillette, J., Caillierez, R., Zommer, N., Alves-Pires, C., Benilova, I., Blum, D., De Strooper, B., and Buee, L. (2012) Neurotoxicity and Memory Deficits Induced by Soluble Low-Molecular-Weight Amyloid-beta(1-42) Oligomers Are Revealed In Vivo by Using a Novel Animal Model. J. Neurosci. 32, 7852-7861.
17. Gong, Y. S., Chang, L., Viola, K. L., Lacor, P. N., Lambert, M. P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Alzheimer's disease-affected brain: Presence of oligomeric A beta ligands (ADDLs) suggests a molecular basis for reversible memory loss. Proc. Natl. Acad. Sci. U.S.A. 100, 10417-10422.
18. Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y. S., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., Krafft, G. A., and Klein, W. L. (2004) Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24, 10191-10200.
19. Lesne, S., Koh, M. T., Kotilinek, L., Kayed, R., Glabe, C. G., Yang, A., Gallagher, M., and Ashe, K. H. (2006) A specific amyloid-beta protein assembly in the brain impairs memory. Nature 440, 352-357.
20. Fukumoto, H., Tokuda, T., Kasai, T., Ishigami, N., Hidaka, H., Kondo, M., Allsop, D., and Nakagawa, M. (2010) High-molecular-weight beta-amyloid oligomers are elevated in cerebrospinal fluid of Alzheimer patients. FASEB J. 24, 2716-2726.
21. Ahmed, M., Davis, J., Aucoin, D., Sato, T., Ahuja, S., Aimoto, S., Elliott, J. I., Van Nostrand, W. E., and Smith, S. O. (2010) Structural conversion of neurotoxic amyloid-beta(1-42) oligomers to fibrils. Nat. Struct. Mol. Biol. 17, 561-U556.
22. Barghorn, S., Nimmrich, V., Striebinger, A., Krantz, C., Keller, P., Janson, B., Bahr, M., Schmidt, M., Bitner, R. S., Harlan, J., Barlow, E., Ebert, U., and Hillen, H. (2005) Globular amyloid beta-peptide(1-42) oligomer - A homogenous and stable neuropathological protein in Alzheimer's disease. J. Neurochem. 95, 834-847.
23. Durakoglugil, M. S., Chen, Y., White, C. L., Kavalali, E. T., and Herz, J. (2009) Reelin signaling antagonizes beta-amyloid at the synapse. Proc. Natl. Acad. Sci. U.S.A. 106, 15938-15943.
24. Noguchi, A., Matsumura, S., Dezawa, M., Tada, M., Yanazawa, M., Ito, A., Akioka, M., Kikuchi, S., Sato, M., Ideno, S., Noda, M., Fukunari, A., Muramatsu, S., Itokazu, Y., Sato, K., Takahashi, H., Teplow, D. B., Nabeshima, Y., Kakita, A., Imahori, K., and Hoshi, M. (2009) Isolation and Characterization of Patient-derived, Toxic, High Mass Amyloid beta-Protein (A beta) Assembly from Alzheimer Disease Brains. J. Biol. Chem. 284, 32895-32905.
25. Lee, E. B., Leng, L. Z., Zhang, B., Kwong, L., Trojanowski, J. Q., Abel, T., and Lee, V. M. Y. (2006) Targeting amyloid-beta peptide (A beta) oligomers by passive immunization with a conformationselective monoclonal antibody improves learning and memory in A beta precursor protein (APP) transgenic mice. J. Biol. Chem. 281, 4292-4299.
26. Lambert, M. P., Velasco, P. T., Chang, L., Viola, K. L., Fernandez, S., Lacor, P. N., Khuon, D., Gong, Y. S., Bigio, E. H., Shaw, P., De Felice, F. G., Krafft, G. A., and Klein, W. L. (2007) Monoclonal antibodies that target pathological assemblies of A beta. J. Neurochem. 100, 23-35.
27. Lambert, M. P., Velasco, P. T., Viola, K. L., and Klein, W. L. (2009) Targeting Generation of Antibodies Specific to Conformational Epitopes of Amyloid beta-Derived Neurotoxins. CNS Neurol. Disord.: Drug Targets 8, 65-81.
28. Xiao, C., Davis, F. J., Chauhan, B. C., Viola, K. L., Lacor, P. N., Velasco, P. T., Klein, W. L., and Chauhan, N. B. (2013) Brain transit and ameliorative effects of intranasally delivered anti-amyloid-beta oligomer antibody in 5XFAD mice. J. Alzheimer's Dis. 35, 777-788.
29. Klein, W. L. (2002) Abeta toxicity in Alzheimer's disease: Globular oligomers (ADDLs) as new vaccine and drug targets. Neurochem. Int. 41, 345-352.
30. Bhaskar, K., Miller, M., Chludzinski, A., Herrup, K., Zagorski, M., and Lamb, B. T. (2009) The PI3K-Akt-mTOR pathway regulates Abeta oligomer induced neuronal cell cycle events. Mol. Neurodegener. 4, 14.
31. Chromy, B. A., Nowak, R. J., Lambert, M. P., Viola, K. L., Chang, L., Velasco, P. T., Jones, B. W., Fernandez, S. J., Lacor, P. N., Horowitz, P., Finch, C. E., Krafft, G. A., and Klein, W. L. (2003) Self-assembly of A beta(1-42) into globular neurotoxins. Biochemistry 42, 12749-12760.
32. Sebollela, A., Freitas-Correa, L., Oliveira, F. F., Paula-Lima, A. C., Saraiva, L. M., Martins, S. M., Mota, L. D., Torres, C., Alves-Leon, S., de Souza, J. M., Carraro, D. M., Brentani, H., De Felice, F. G., and Ferreira, S. T. (2012) Amyloid-beta Oligomers Induce Differential Gene Expression in Adult Human Brain Slices. J. Biol. Chem. 287, 7436-7445.
33. Velasco, P. T., Heffern, M. C., Sebollela, A., Popova, I. A., Lacor, P. N., Lee, K. B., Sun, X., Tiano, B. N., Viola, K. L., Eckermann, A. L., Meade, T. J., and Klein, W. L. (2012) Synapse-binding subpopulations of Abeta oligomers sensitive to peptide assembly blockers and scFv antibodies. ACS Chem. Neurosci. 3, 972-981.
34. Lambert, M. P., Viola, K. L., Chromy, B. A., Chang, L., Morgan, T. E., Yu, J. X., Venton, D. L., Krafft, G. A., Finch, C. E., and Klein, W. L. (2001) Vaccination with soluble A beta oligomers generates toxicity-neutralizing antibodies. J. Neurochem. 79, 595-605.
35. Prin, C., Bene, M. C., Gobert, B., Montagne, P., and Faure, G. C. (1995) Isoelectric restriction of human immunoglobulin isotypes. Biochim. Biophys. Acta 1243, 287-289.
36. San Paulo, A., and Garcia, R. (2000) High-resolution imaging of antibodies by tapping-mode atomic force microscopy: Attractive and repulsive tip-sample interaction regimes. Biophys. J. 78, 1599-1605.
37. Martinez, N. F., Lozano, J. R., Herruzo, E. T., Garcia, F., Richter, C., Sulzbach, T., and Garcia, R. (2008) Bimodal atomic force microscopy imaging of isolated antibodies in air and liquids. Nanotechnology 19, 384011.
38. Porath, J. (1963) Some recently developed fractionation procedures and their application to peptide and protein hormones. Pure Appl. Chem. 6, 233-244.
39. Bhushan, B., Tokachichu, D. R., Keener, M. T., and Lee, S. C. (2005) Morphology and adhesion of biomolecules on silicon based surfaces. Acta Biomater 1, 327-341.
40. Bolshakova, A. V., Kiselyova, O. I., Filonov, A. S., Frolova, O. Y., Lyubchenko, Y. L., and Yaminsky, I. V. (2001) Comparative studies of bacteria with an atomic force microscopy operating in different modes. Ultramicroscopy 86, 121-128.
41. Shekhawat, G. S., Lambert, M. P., Sharma, S., Velasco, P. T., Viola, K. L., Klein, W. L., and Dravid, V. P. (2009) Soluble state high resolution atomic force microscopy study of Alzheimer's beta-amyloid oligomers. Appl. Phys. Lett., 95.
42. Mustata, G. M., Shekhawat, G. S., Lambert, M. P., Viola, K. L., Velasco, P. T., Klein, W. L., and Dravid, V. P. (2012) Insights into the mechanism of Alzheimer's beta-amyloid aggregation as a function of concentration by using atomic force microscopy. Appl. Phys. Lett. 100, 133704.
43. Pitt, J., Roth, W., Lacor, P., Smith, A. B., Blankenship, M., Velasco, P., De Felice, F., Breslin, P., and Klein, W. L. (2009) Alzheimer's-associated A beta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. Toxicol. Appl. Pharmacol. 240, 189-197.
44. Brewer, G. J., Torricelli, J. R., Evege, E. K., and Price, P. J. (1993) Optimized Survival of Hippocampal-Neurons in B27-Supplemented Neurobasal, a New Serum-Free Medium Combination. J. Neurosci. Res. 35, 567-576.